🔗 Permalink

Inventor profile of:

Andreas KUHN

City:

Mainz

Country:

Germany

Published Applications:

Last publication date:

2026-04-23

Top Assignees for applications by Andreas KUHN

The entities that hold a legal rights for patent applications filed by inventor KUHN Andreas:

BioNTech SE 9 Mainz, Germany
TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH 4 Mainz, Germany
BioNTech RNA Pharmaceuticals GmbH 2 Mainz, Germany
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Unive 1 Mainz, Germany
UNIWERSYTET WARSZAWSKI 1 Warszawa, Poland
TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH 1 Mainz, Germany
OCV Intellectual Capital, LLC 1 Toledo, OH United States
BIONTECH AG 1 Mainz, Germany

Recent patent applications by KUHN Andreas

Andreas KUHN from Mainz, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23

US20260109727A1

Chemistry; metallurgy

RNA CONSTRUCTS AND USES THEREOF

#2 | 2025-12-25

US20250388944A1

Chemistry; metallurgy

IN VITRO TRANSCRIPTION TECHNOLOGIES

#3 | 2025-07-31

US20250242059A1

Human necessities

CORONAVIRUS VACCINE

#4 | 2025-01-09

US20250011797A1

Chemistry; metallurgy

STABILIZATION OF POLY(A) SEQUENCE ENCODING DNA SEQUENCES

#5 | 2024-04-04

US20240110214A1

Chemistry; metallurgy

RNA MANUFACTURING

#6 | 2024-03-07

US20240075165A1

Human necessities

Coronavirus vaccine

#7 | 2024-01-04

US20240002127A1

Performing operations; transporting

CORONAVIRUS VACCINE

#8 | 2023-08-31

US20230272406A1

Chemistry; metallurgy

3'-UTR SEQUENCES FOR STABILIZATION OF RNA

#9 | 2023-06-15

US20230183769A1

Chemistry; metallurgy

In vitro transcription technologies

#10 | 2023-03-09

US20230075979A1

Human necessities

Coronavirus vaccine

#11 | 2023-03-09

US20230073461A1

Human necessities

CORONAVIRUS VACCINE

#12 | 2023-01-10

US17233396

Human necessities

Coronavirus vaccine

#13 | 2022-09-01

US20220273820A1

Human necessities

RNA constructs and uses thereof

#14 | 2022-08-11

US20220249704A1

Human necessities

RNA constructs and uses thereof

#15 | 2021-11-25

US20210363172A1

Chemistry; metallurgy

5′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapy

#16 | 2021-11-04

US20210340170A1

Chemistry; metallurgy

5'-CAP COMPOUNDS AND THEIR USES IN STABILIZING RNA, EXPRESSING PROTEINS AND IN THERAPY

#17 | 2020-12-17

US20200392518A1

Chemistry; metallurgy

Stabilization of poly(A) sequence encoding DNA sequences

#18 | 2020-11-19

US20200362313A1

Chemistry; metallurgy

METHOD OF ENHANCING RNA EXPRESSION IN A CELL

#19 | 2019-03-07

US20190071682A1

Chemistry; metallurgy

3′-UTR sequences for stabilization of RNA

#20 | 2017-06-15

US20170166905A1

Chemistry; metallurgy

Stabilization of poly(A) sequence encoding DNA sequences

#21 | 2012-08-02

US20120195917A1

Human necessities

Vaccine composition comprising 5′-cap modified RNA

InventorID:

1901969 ⎘